Synonyms: Example 1 [WO2005118554A2] | PCI27483
Compound class:
Synthetic organic
Comment: PCI-27483 is a small molecule inhibitor of activated factor VII (FVIIa). A complex of FVIIa and tissue factor are involved in promoting cell migration and angiogenesis and may contribute to tumour invasiveness via this mechanism. Inhibiting FVIIa is being investigated for anti-tumour potential [3].
|
|
References |
1. Dickman DA, Kumar DV, O'bryan C, Rai R, Shrader WD, Wesson K. (2005)
Factor viia inhibitor. Patent number: WO2005118554A2. Assignee: Pharmacyclics, Inc.. Priority date: 02/06/2004. Publication date: 15/12/2005. |
2. Hu X, Shrimp JH, Guo H, Xu M, Chen CZ, Zhu W, Zakharov AV, Jain S, Shinn P, Simeonov A et al.. (2021)
Discovery of TMPRSS2 Inhibitors from Virtual Screening as a Potential Treatment of COVID-19. ACS Pharmacol Transl Sci, 4 (3): 1124-1135. [PMID:34136758] |
3. Ramanathan RK, Thomas GW, Khorana AA, Shah S, Zhou C, Wong S, Cole Jr G, James D, Gabrail NY. (2019)
A Phase 2 Study of PCI-27483, a Factor VIIa Inhibitor in Combination with Gemcitabine for Advanced Pancreatic Cancer. Oncology, 96 (4): 217-222. [PMID:30844808] |